A. Bruce Moore Jr. - 16 Feb 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: Group President - Service Line
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 16 Feb 2022
Net transactions value: -$7,406,188
Form type: 4
Filing time: 18 Feb 2022, 17:47:09 UTC
Previous filing: 01 Feb 2022
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Sale	$5,034,685	-20,633	-17%	$244.01	101,155	16 Feb 2022	Direct	F1
transaction	HCA	Common Stock	Sale	$2,371,502	-9,367	-9.3%	$253.18	91,788	17 Feb 2022	Direct	F2
holding	HCA	Common Stock						40,552	16 Feb 2022	By MAM Trust (Spouse, Trustee)
holding	HCA	Common Stock						44,498	16 Feb 2022	By MRM Trust (Spouse, Trustee)
holding	HCA	Common Stock						40,552	16 Feb 2022	By TCM Trust (Spouse, Trustee)
holding	HCA	Common Stock						51,096	16 Feb 2022	By 2018 GRAT
holding	HCA	Common Stock						100,000	16 Feb 2022	By 2021 GRAT

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.00 to $244.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.10 to $253.45, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.00 to $244.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.10 to $253.45, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.